Search results for "target"

showing 10 items of 1196 documents

Polymer-based systems for controlled release and targeting of drugs

2019

The current need to find new advanced approaches to carry biologically active substances (conventional organic drugs, peptides, proteins (such as antibodies), and nucleic acid-based drugs (NABDs such as siRNA and miRNA)) in the body fluids, to realize targeted therapies and even personalized ones, goes hand in hand with research on the performance of new materials to better realize appropriate drug vectors [...]

Drugchemistry.chemical_classificationPolymers and PlasticsChemistrymedia_common.quotation_subjectNew materialspolymers drug release drug targetingGeneral ChemistryComputational biologyPolymerControlled releaseEditorialNucleic acidBiologically active substancesmedia_common
researchProduct

Calixarene: A Versatile Material for Drug Design and Applications

2016

The therapy of various diseases by the drugs entrapped in calixarene derivatives is gaining attraction of researchers nowadays. Calixarenes are macrocyclic nano-baskets which belong to cavitands class of host-guest chemistry. They are the marvelous hosts with distinct hydrophobic three dimensional cavities to entrap and encapsulate biologically active guest drugs. Calixarene and its derivatives develop inclusion complexes with various types of drugs and vitamins for their sustained/targeted release. Calixarene and its derivatives are used as carriers for anti-cancer, anti-convulsant, anti-hypertensive, anthelmentic, anti-inflammatory, antimicrobial and antipsychotic drugs. They are the impo…

Drugmedia_common.quotation_subjectAnti-Inflammatory AgentsSupramolecular chemistrymacromolecular substances010402 general chemistry01 natural sciencesAnti-Infective AgentsDrug DiscoveryCalixareneHumansOrganic chemistryProdrugsAntihypertensive AgentsTargeted releasemedia_commonAnthelminticsPharmacologyDrug Carriers010405 organic chemistryChemistryProdrugBiocompatible material0104 chemical sciencesDrug DesignDrug releaseAnticonvulsantsCalixarenesAntipsychotic AgentsCurrent Pharmaceutical Design
researchProduct

Selected Secondary Plant Metabolites for Cancer Therapy

2015

Secondary plant metabolites reveal numerous biological activities making them attractive as resource for drug development of human diseases. As the majority of cancer drugs clinically established during the past half century is derived from nature, cancer researchers worldwide try to identify novel natural products as lead compounds for cancer therapy. Natural products are considered as promising cancer therapeutics, either as single agents or in combination protocols, to enhance the antitumor activity of additional therapeutic modalities. Most natural compounds exert pleotrophic effects and modulate various signal transduction pathways. A better understanding of the complex mechanisms of a…

Drugmedia_common.quotation_subjectPhytochemicalsApoptosisDrug developmentResveratrolBiologyPharmacologychemistry.chemical_compoundBetulinic acidmedicineddc:610media_commonlcsh:R5-920Epidermal growth factor receptorCancerBioactivity-guided fractionationmedicine.diseaseSmall moleculeTargeted tumor therapyComplementary and alternative medicinechemistryDrug developmentDrug resistanceCancer celllcsh:Medicine (General)Camptothecinmedicine.drugWorld Journal of Traditional Chinese Medicine
researchProduct

Relevancia clínica de la selectividad de los inhibidores del cotransportador sodio-glucosa tipo 2

2016

Selectivity is the property of a drug to preferentially bind to a biological structure. Most drugs can bind and stimulate or inhibit more than one system. Therefore, it is important that they are selective for the intended site and that the doses used do not have effects on other sites, which could provoke adverse reactions. Selectivity is assessed through in vitro experiments on organs or isolated cells. If the aim is to compare drugs, the experiment should be conducted in the same tissue and with the same design. Even so, the results cannot be directly extrapolated to clinical practice due to the influence of pharmacokinetic properties, which allow an adequate dose of the drug to reach th…

Drugmedicine.medical_specialtybusiness.industrymedia_common.quotation_subject030209 endocrinology & metabolismTransporterGeneral Medicine030204 cardiovascular system & hematologyPharmacologyIn vitroSurgery03 medical and health sciences0302 clinical medicinePharmacokineticsTarget sitePharmacodynamicsBiological structuremedicineSelectivitybusinessmedia_commonMedicina Clínica
researchProduct

Nanocarriers for respiratory diseases treatment: Recent advances and current challenges

2014

Pulmonary delivery of locally-acting drugs encapsulated in nanocarriers provides several advantages for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary diseases, cystic fibrosis, tuberculosis and lung cancer. These advantages include, among others, sustained drug delivery to the lungs, reduced therapeutic dose and improved patient compliance. The aim of this review is to give an updated overview on recent advances recorded in the last few years in this field as well as on the major challenges still existing and that remain to be overcome before any clinical application. After an outline on the cellular and extracellular barriers affecting drug delivery to…

Drugmedicine.medical_specialtymedia_common.quotation_subjectpulmonary deliveryAntitubercular AgentsMicrobial Sensitivity TestsGene deliveryPharmacologyCystic fibrosisTherapeutic indexDrug DiscoverymedicineAnimalsHumansTuberculosisIntensive care medicinemedia_commonDrug CarriersLungrespiratory diseasesbusiness.industryMycobacterium tuberculosisGeneral Medicinemedicine.diseaseinhalation of polymeric- and lipid-based nanocarriermedicine.anatomical_structurelung targetingTargeted drug deliveryDrug deliverymucus penetrationNanoparticlesNanocarriersbusinessDefense mechanism
researchProduct

On American Drone Strikes And (Possible) European Responsibilities: Facing The Issue Of Jurisdiction For “Complicity” In Extraterritorial Targeted Ki…

2019

States Party to the European Convention of Human Rights (ECHR) regularly provide third States with key aid or assistance in performing extraterritorial targeted killings through armed drones: by doing so, they can be said to engage in conduct amounting to “complicity” for the purposes of international law of State responsibility. Strictly speaking, however, ECHR provisions do not apply to such conduct, which cannot be included into existing models of “jurisdiction” as per Article 1 ECHR – namely, “spatial” and “personal”. This results in a troublesome legal vacuum. The present article proposes an appraisal of such conduct through the lenses of a third jurisdictional model, already acknowled…

ECHRjurisdictioncomplicitydroneextraterritorial targeted killing
researchProduct

Sequence variation and regulatory variation in acetylcholinesterase genes contribute to insecticide resistance in different populations of Leptinotar…

2021

Abstract Although insect herbivores are known to evolve resistance to insecticides through multiple genetic mechanisms, resistance in individual species has been assumed to follow the same mechanism. While both mutations in the target site insensitivity and increased amplification are known to contribute to insecticide resistance, little is known about the degree to which geographic populations of the same species differ at the target site in a response to insecticides. We tested structural (e.g., mutation profiles) and regulatory (e.g., the gene expression of Ldace1 and Ldace2, AChE activity) differences between two populations (Vermont, USA and Belchow, Poland) of the Colorado potato beet…

Ecologyorganophosphatetarget site mutationkoloradonkuoriainencarbamatekarbamaatitinsecticide resistancecarbamate; gene expression; insecticide resistance; organophosphate; target site mutationinsektisiditresistenssipopulaatiogenetiikkagene expressiongeeniekspressiomutaatiotQH540-549.5Research ArticlesResearch Article
researchProduct

An Integrated Approach to Surveying Emigrants Worldwide

2019

AbstractThis chapter describes the research design applied in the research project The Emigrant Communities of Latvia: National Identity, Transnational Relations and Diaspora Politics, which forms the empirical core of this volume. It discusses this methodology in the context of other migration studies and major surveys on migration. Compared to previous studies The Emigrant Communities of Latvia is the most inclusive in terms of the target audience. All Latvians and Latvian nationals abroad were invited to participate in the survey, applying a broad and open definition of ‘Latvian diaspora’ based on personal identification with the Latvian nation and/or citizenship. Being Web-based, the su…

Economic growth05 social sciencesTarget audienceLatvianContext (language use)language.human_language0506 political scienceDiasporaMigration studiesPolitical science0502 economics and businessRespondentNational identity050602 political science & public administrationlanguageDiaspora politics050207 economics
researchProduct

Interest rates, expectations and the credibility of the Bank of Spain

1995

The purpose of the paper is to pinpoint the date of the change of monetary policy regime which occurred in Spain during the year 1984, when it moved away from controlling monetary aggregates towards interest rate targeting. The most likely date for the change is estimated and, surprisingly, there is evidence that agents learned about the new intermediate target quite rapidly.A week after the change, the term structure of interest rates showed how market agents attributed much more informational content to interest rate changes than they had previously. Two types of transitions are tried: a one-step and a gradual logistic swithing function.

Economics and EconometricsInflation targetingmedia_common.quotation_subjectMonetary policyMonetary economicsMonetary hegemonyForward guidanceInterest rateCredit channelCredibilityEconomicssense organsYield curveskin and connective tissue diseasesmedia_commonApplied Economics
researchProduct

Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer.

2007

Cytotoxic chemotherapies are standard of care for patients suffering from advanced non-small cell lung cancer (NSCLC). However, objective responses are only achieved in 20% of cases and long-term survival is rarely observed. Clinically applied anticancer drugs exert at least some of their activities by inducing apoptosis. A critical step in apoptotic signal transduction is the permeabilization of the mitochondrial outer membrane (MOM), which is regulated by the BCL-2 family of proteins. Hence, therapeutic targeting of BCL-2 proteins is a promising approach to increase the drug-sensitivity of cancers. To this end we have assessed the impact of conditional expression of the proapoptotic multi…

ElectrophoresisCancer ResearchProgrammed cell deathLung NeoplasmsPaclitaxelmedicine.medical_treatmentImmunoblottingAntineoplastic AgentsApoptosisDrug resistanceBiologyPermeabilityPiperazinesTargeted therapyNitrophenolsCarcinoma Non-Small-Cell LungCell Line TumormedicineCytotoxic T cellHumansLung cancerEtoposideSulfonamidesBcl-2 familyBiphenyl CompoundsButylated Hydroxytoluenemedicine.diseaseFlow CytometryImmunohistochemistryMitochondriaNeoplasm ProteinsGene Expression Regulation Neoplasticbcl-2 Homologous Antagonist-Killer ProteinOncologyProto-Oncogene Proteins c-bcl-2ApoptosisDoxorubicinDrug Resistance NeoplasmImmunologyCancer researchMyeloid Cell Leukemia Sequence 1 ProteinSignal transductionSignal TransductionInternational journal of cancer
researchProduct